These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5311514)

  • 1. Arrest of hyperparathyroid bone disease with dihydrotachysterol in patients undergoing chronic hemodialysis.
    Kaye M; Chatterjee G; Cohen GF
    Ann Intern Med; 1970 Aug; 73(2):225-33. PubMed ID: 5311514
    [No Abstract]   [Full Text] [Related]  

  • 2. Arrest of hyperparathyroid bone disease by the use of dihydrotachysterol in patients undergoing chronic hemodialysis.
    Kaye M; Chatterjee G; Cohen GF; Borra S; Sagar S
    Trans Assoc Am Physicians; 1970; 83():245-53. PubMed ID: 5505392
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evolving aspects of uremic osteodystrophy in the dialized patient].
    Zucchelli P; Fusaroli M; Fabbri L; Catizone L; Pavlica P; Viglietta G; Casanova S
    J Urol Nephrol (Paris); 1976; 82(4-5):325-8. PubMed ID: 940176
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of calciferol and its metabolites on patients with chronic renal failure. I. Calciferol, dihydrotachysterol, and calcifediol.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 May; 143(5):960-3. PubMed ID: 6089682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative biological effects of vitamins D 2 and D 3 and dihydrotachysterol 2 and dihydrotachysterol 3 in the chick.
    Hibberd KA; Norman AW
    Biochem Pharmacol; 1969 Oct; 18(10):2347-55. PubMed ID: 4327385
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
    Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
    N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between the results of radiocalcium studies and histological findings in a case of primary hyperparathyroidism (osteitis fibrosa cystica generalisata of von Recklinghausen) before and after removal of parathyroid adenoma.
    Caniggia A; Gennari C; Guideri R; Cesari L
    J Clin Endocrinol Metab; 1966 Aug; 26(8):867-74. PubMed ID: 5921154
    [No Abstract]   [Full Text] [Related]  

  • 8. [ALBRIGHT'S HEREDITARY OSTEODYSTROPHY].
    SCHOENGUT L; CSERHATI E
    Acta Paediatr Acad Sci Hung; 1963; 4():373-88. PubMed ID: 14121969
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of dihydrotachysterol and calciferol.
    Kaye M; Just G; Wilson M
    Can J Physiol Pharmacol; 1971 Oct; 49(10):857-61. PubMed ID: 5316524
    [No Abstract]   [Full Text] [Related]  

  • 10. A calcium kinetic approach to the problem of renal osteodystrophy.
    Gonick HC; Drinkard JP; Hertoghe J; Rubini ME
    Clin Orthop Relat Res; 1974 May; (100):315-36. PubMed ID: 4838415
    [No Abstract]   [Full Text] [Related]  

  • 11. Deterioration of renal bone disease in patients treated with salmon calcitonin.
    Cundy T; Kanis JA; Heynen G; Paton S; Earnshaw M; Woods CG
    Clin Endocrinol (Oxf); 1982 Jan; 16(1):29-37. PubMed ID: 7042129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone loss in hemodialysis patients].
    Inaba M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():521-5. PubMed ID: 18161159
    [No Abstract]   [Full Text] [Related]  

  • 13. Normocalcemic primary hyperparathyroidism with osteitis fibrosa.
    Frame B; Foroozanfar F; Patton RB
    Ann Intern Med; 1970 Aug; 73(2):253-7. PubMed ID: 5454261
    [No Abstract]   [Full Text] [Related]  

  • 14. Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis.
    de Fremont JF; Sebert JL; Gueris J; Marie P; Coevoet B; Makdassi R; Lambrey G; Meunier P; Fournier A
    Proc Eur Dial Transplant Assoc; 1979; 16():675-6. PubMed ID: 232918
    [No Abstract]   [Full Text] [Related]  

  • 15. PSEUDOHYPOPARATHYROIDISM WITH OSTEITIS FIBROSA CYSTICA AND IMPAIRED ABSORPTION OF CALCIUM.
    BELL NH; GERARD ES; BARTTER FC
    J Clin Endocrinol Metab; 1963 Aug; 23():759-62. PubMed ID: 14059552
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone disease in hemodialysis patients with particular reference to the effect of fluoride.
    Cordy PE; Gagnon R; Taves DR; Kaye M
    Can Med Assoc J; 1974 Jun; 110(12):1349-53. PubMed ID: 4834525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of osteomalacia in secondary hyperparathyroidism after gastrectomy.
    Wortsman J; Pak CY; Bartter FC; Deftos L; Delea CS
    Am J Med; 1972 Apr; 52(4):556-64. PubMed ID: 5017248
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteitis fibrosa cystica and secondary hyperparathyroidism in multiple myeloma.
    Bains MA; Pardoe LE; Rudin CE
    Br J Haematol; 2007 Jan; 136(2):179. PubMed ID: 17062009
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitamin-D deficiency and primary hyperparathyroidism.
    Woodhouse NJ; Doyle FH; Joplin GF
    Lancet; 1971 Aug; 2(7719):283-6. PubMed ID: 4104976
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudohypoparathyroidism with raised plasma alkaline phosphatase.
    Cohen RD; Vince FP
    Arch Dis Child; 1969 Feb; 44(233):96-101. PubMed ID: 5304559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.